BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26845209)

  • 1. [Use of rituximab in primary and secondary glomerulonephritis].
    Insalaco M; Zanoli L; Fatuzzo P; Fiorini F; Granata A
    G Ital Nefrol; 2015; 32(6):. PubMed ID: 26845209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An innovative approach to the treatment of immune-mediated glomerular diseases].
    Roccatello D
    G Ital Nefrol; 2013; 30(1):. PubMed ID: 23832439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunotherapy mechanisms in glomerulonephritis].
    Polci R; Feriozzi S
    G Ital Nefrol; 2011; 28(6):612-21. PubMed ID: 22167612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of crescentic glomerulonephritis: what are the recent advances?
    Li X; Chen N
    Contrib Nephrol; 2013; 181():229-39. PubMed ID: 23689584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of monoclonal antibodies in the treatment of immune-mediated kidney disease: the state of the art].
    Cravedi P
    G Ital Nefrol; 2012; 29(3):274-82; discussion 292. PubMed ID: 22718450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal disease in ANCA-associated vasculitis].
    Vanhille P; Vrigneaud L; Quéméneur T
    Presse Med; 2012 Mar; 41(3 Pt 1):247-53. PubMed ID: 22265953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD20 therapy and pauci-immune crescentic glomerulonephritis.
    Shu KH; Chiang WC; Chiu YL
    J Formos Med Assoc; 2017 Apr; 116(4):215-216. PubMed ID: 26786252
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.
    Ravani P; Bonanni A; Rossi R; Caridi G; Ghiggeri GM
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):710-20. PubMed ID: 26585985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monoclonal antibodies in nephrology: a delicate balance between curative potential, evidence of effectiveness, and toxicity].
    Magistroni R
    G Ital Nefrol; 2012; 29(3):283-91; discussion 292. PubMed ID: 22718451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-cell depleting agents for ANCA vasculitides: a new therapeutic approach.
    Gómez-Puerta JA; Quintana LF; Stone JH; Ramos-Casals M; Bosch X
    Autoimmun Rev; 2012 Jul; 11(9):646-52. PubMed ID: 22146313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab treatment of fibrillary glomerulonephritis.
    Collins M; Navaneethan SD; Chung M; Sloand J; Goldman B; Appel G; Rovin BH
    Am J Kidney Dis; 2008 Dec; 52(6):1158-62. PubMed ID: 18823685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of rituximab therapy in glomerulonephritis.
    Jayne D
    J Am Soc Nephrol; 2010 Jan; 21(1):14-7. PubMed ID: 18799717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monoclonal antibodies to B-lymphocytes (rituximab) in the treatment of HCV-associated severe cryoglobulinemic glomerulonephritis].
    Milovanova SIu; Lopatkina TN; Kozlovskaia LV; Krasnova TN
    Ter Arkh; 2007; 79(6):69-72. PubMed ID: 17684972
    [No Abstract]   [Full Text] [Related]  

  • 14. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
    Timlin H; Lee SM; Manno RL; Seo P; Geetha D
    Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMV gastric ulcer in a patient with pauci immune crescentic glomerulonephritis on rituximab - a rare combination.
    Ishtiaq R; Wilhelm DM; Ahmad S
    Postgrad Med; 2019 Nov; 131(8):619-622. PubMed ID: 31506001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab for the treatment of glomerulonephritis in hepatitis C associated cryoglobulinaemia.
    Korte MR; van Heerde MJ; de Man RA; Betjes MH
    Neth J Med; 2008 Jan; 66(1):27-30. PubMed ID: 18219065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab in mixed cryoglobulinemia: increased experience and perspectives.
    De Vita S; Quartuccio L; Fabris M
    Dig Liver Dis; 2007 Sep; 39 Suppl 1():S122-8. PubMed ID: 17936213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and management of small vessel vasculitides].
    Pettersson T; Karjalainen A
    Duodecim; 2010; 126(12):1496-507. PubMed ID: 20617753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.
    Terrier B; Launay D; Kaplanski G; Hot A; Larroche C; Cathébras P; Combe B; de Jaureguiberry JP; Meyer O; Schaeverbeke T; Somogyi A; Tricot L; Zénone T; Ravaud P; Gottenberg JE; Mariette X; Cacoub P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1787-95. PubMed ID: 20740617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of post-transplant glomerulonephritis].
    Sandrini S; Valerio F
    G Ital Nefrol; 2008; 25 Suppl 44():99-106. PubMed ID: 19048593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.